New recommendations have been issued for when you should get breast cancer mammograms and cervical-cancer screenings. Nancy Marshall Genzer reports some doctors believe patients need to change their mindsets.
Paul Fronstin, a senior research associate with the Employee Benefit Research Institute, talks with Tess Vigeland about what to expect from next year's employer health plans.
With the end of the year fast-approaching, people want to make sure they've milked their health-care benefits for all they can, from spending what's left in FSA's to finally getting those annual physical exams. Joel Rose reports.
A lot of big numbers have been thrown around for the health-care overhaul bills in Congress. But how would the plans actually help the average family of four with no insurance? Nancy Marshall Genzer reports.
The Congressional Budget Office has been crunching the numbers to find out how much the Senate health-care overhaul will cost. Nancy Marshall Genzer reports the bill's opponents are having a field day.
A new study is raising more questions about Merck's cholesterol drugs. Prescription rates for Zetia and Vytorin, the drugs in the unfavorable report, have fallen 20 percent in two years. Jennifer Collins reports.
The FDA is considering developing rules for how drug companies can advertise online. Reporter Nancy Marshall Genzer talks the details with Steve Chiotakis.
The mentally disabled want to work as much as anybody does, but jobs for them are even tougher to come by — especially during a recession. David Martin Davies reports.
